Gilead Sciences

CompanyPharma

US biopharmaceutical company.

Minutes holds 1 development naming Gilead Sciences, recorded from October 2026.

Gilead Sciences

Gilead reports 23% placebo-adjusted remission for colitis pill in Phase 2

Gilead SciencesPharma19 OctStatnews

Elsewhere in Pharma

Past 3 months in Activity →

Novo Nordisk reports 25% average weight loss for CagriSema in women in a new analysis

Novo NordiskPharma20 OctCNBC

Roche signs antibody-drug conjugate deal with Hansoh worth up to $15 billion

PartnershipRoche, Hansoh Pharmaceutical Group, +1Pharma19 OctBioPharma Dive